Gene therapy for vein graft failure (Q38081951)

28 August 2017

title

Gene therapy for vein graft failure (English)

1 reference

28 August 2017

0 references

Xiao-Wen Wang

1

1 reference

28 August 2017

Xing-Ji Zhao

series ordinal

2

1 reference

28 August 2017

Xiao-Yong Xiang

series ordinal

3

1 reference

28 August 2017

publication date

17 February 2013

1 reference

Journal of Cardiac Surgery

28 August 2017

published in

1 reference

28 August 2017

volume

28

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

144-147

1 reference

Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies.

28 August 2017

cites work

1 reference

Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins

21 January 2018

1 reference

Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention

21 January 2018

1 reference

Gene therapy to prevent occlusion of venous bypass grafts

21 January 2018

1 reference

Pathophysiology of aortocoronary saphenous vein bypass graft disease

21 January 2018

1 reference

Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.

21 January 2018

1 reference

VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries

21 January 2018

1 reference

Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months

21 January 2018

1 reference

Rapid development of vein graft atheroma in ApoE-deficient mice

21 January 2018

1 reference

Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts.

21 January 2018

1 reference

Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury

21 January 2018

1 reference

Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model

21 January 2018

1 reference

Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production

21 January 2018

1 reference

Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts

21 January 2018

1 reference

Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia

21 January 2018

1 reference

Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.

21 January 2018

1 reference

Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy

21 January 2018

1 reference

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

21 January 2018

1 reference

The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics

21 January 2018

1 reference

Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial

21 January 2018

1 reference

Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

Getting to the root of miRNA-mediated gene silencing

21 January 2018

1 reference

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

MicroRNAs add a new dimension to cardiovascular disease

21 January 2018

1 reference

MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation

21 January 2018

1 reference

MicroRNAs: role in cardiovascular biology and disease

21 January 2018

1 reference

MicroRNAs in Vascular Disease

21 January 2018

1 reference

MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation

21 January 2018

1 reference

A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia

21 January 2018

1 reference

Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster

21 January 2018

1 reference

MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease

21 January 2018

1 reference

The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease

21 January 2018

1 reference

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

21 January 2018

1 reference

The miR-143/145 Cluster Is a Novel Transcriptional Target of Jagged-1/Notch Signaling in Vascular Smooth Muscle Cells

21 January 2018

1 reference

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

21 January 2018

1 reference

Stem cells and transplant arteriosclerosis

21 January 2018

1 reference

MicroRNA-145 Targeted Therapy Reduces Atherosclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JOCS.12075

1 reference

28 August 2017

1 reference